Delivery Order SPE2DB22D2206-SPE2DB25FJV26
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,284.84 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 250 mg capsules (500 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $2,662.25 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 200 mg/mL suspension in 160 mL quantities. The contract, awarded on July 29, 2025, with a completion date of July 30, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Mycophenolate 500 mg tablets (500 count) valued at $1,676.36. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The award was made through open competition with no set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Mycophenolic Acid DR 360 mg Tablets (120 count). The order has a potential value of $1,660.86 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and the product will be delivered from the company's facilities in Conshohocken, Pennsylvania. This delivery order is part of a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $39,149.57 to AmerisourceBergen Drug Corp on August 22, 2025, with an ultimate completion date of the same date. This firm fixed-price delivery order represents a non-competitive award under a larger indefinite delivery contract vehicle and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,912.76 to AmerisourceBergen Drug Corp on August 25, 2025, with completion targeted for August 26, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $2,576.70 firm fixed price delivery order (Contract No. 4569046853) to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside contract represents a child order issued under a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,126.93 to AmerisourceBergen Drug Corp on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive procurement, represents a child contract action for pharmaceutical and medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,963.84 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, issued under contract number 4569048102, represents a non-set-aside competitive award to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,586.87 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJV26Delivery Order
The Defense Logistics Agency awarded a $1,346.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg vials. This contract, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-competitive set-aside delivery order executed through the company's existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving military and veteran healthcare systems. The order will be fulfilled from the company's Conshohocken facility and involves the delivery of this pharmaceutical product to support federal healthcare requirements. This delivery order is issued under AmerisourceBergen Drug Corp's prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of medications, vaccines, medical supplies, and specialty pharmaceuticals to support military healthcare programs worldwide. The Mycophenolate delivery represents one of numerous product lines managed through this primary contract vehicle, which serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with flexible pharmaceutical procurement capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/8/25 |